Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes

Current Eye Research

Volumn 17, Issue 2, 1998, Pages 165-173

  Ksander, Bruce R ^a   Geer, David C ^a   Chen, Peter W ^a   Salgaller, Michael L ^b   Rubsamen, Patrick ^c   Murray, Timothy G ^c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b Northwest Biotherapeutics Inc   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxic T cells; Human; Ocular melanoma; Tumor immunology; Tumor infiltrating lymphocytes

Indexed keywords

CHROMIUM 51; HLA ANTIGEN CLASS 1; INTERLEUKIN 2;

ANTIGEN EXPRESSION; ARTICLE; CELL KILLING; CHOROID MELANOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CULTURE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UVEA MELANOMA;

EID: 0031930924     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.2.165.5607     Document Type: Article

References (24)

1. de la Cruz, P. O., Specht, C. S. and McLean, I. W. (1990) Lymphocytic infiltration in uveal malignant melanoma. Cancer, 65, 112-115.
2. Whelchel, J. C., Farah, S. E., McLean, I. W. and Burnier Jr., M. N. (1993) Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest. Ophthalmol. Vis. Sci. 34, 2603-2606.
3. Ksander, B. R., Rubsamen, P. E., Olsen, K. R., Cousins, S. W. and Streilein, J. W. (1991) Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest. Ophthalmol. Vis. Sci. 32, 198-208.
4. Kawakami, Y., Eliyahu, S., Skaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appelaa, E. and Rosenberg, S. A. (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor-infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
5. Topalian, S. L., Solomon, D. and Rosenberg, S. A. (1989) Tumor specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142, 3714-3725.
6. Kawakami, Y., Nishimur, M. I. and Restifo, N. P. (1993) T cell recognition of human melanoma antigens. J. Immunother. 14, 88-93.
7. Basse, P., Herberman, R. B., Nannmark, U., Johansson, B. R., Hokland, M., Wasserman, K. and Goldfarb, R. H. (1991) Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J. Exp. Med. 174, 479-488.
8. Grimm, E. A., Robb, R. J., Roth, J. A., Neckers, L. M., Lachman, L. B. and Wilson, D. J. (1983) Lymphokine-activated killer cell phenomenon: III. evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J. Exp. Med. 158, 1356-1361.
9. Rayner, A. A., Grimm, E. A., Lotze, M. T., Wilson, D. J. and Rosenberg, S. A. (1985) Lymphokine-activated killer (LAK) cell phenomenon: IV. lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. J. Natl. Cancer Inst. 75, 67-75.
10. Grimm, E. A., Mazumder, A., Zhang, H. Z. and Rosenberg, S. A. (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155, 1823-1841.
11. Aebersold, P., Hyatt, C., Jonson, S., Hines, K., Korcak, L., Sanders, M., Lootze, M., Topalian, S. L., Yang, J. and Rosenberg, S. A. (1991) Lysis of autologous melanoma cells by tumor infiltrating-lymphocytes: association with clinical response. J. Natl. Cancer Inst. 83, 932-937.
12. Marincola, F. M., Shamamian, P. and Simonis, T. B. (1994) Locus-specific analysis of human leukocyte antigens class I expression in melanoma cell lines. J. Immunother. 16, 13-23.
13. Van Pel, A., van der Bruggen, P., Coulie, P. G., Brichard, V G., Lethe, B., van den Eynde, B., Uyttenhove, C., Renauld, J.-C. and Boon, T. (1995) Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunological Rev. 145, 229-250.
14. Hom, S. S., Topalian, S. L., Simonis, T., Mancini, M. and Rosenberg, S. A. (1991) Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating-lymphocytes: analysis by human lymphocyte antigen restriction. J. Immunother. 10, 153-164.
15. Topalian, S. L., Hom, S. S., Kawakami, Y., Mancini, M., Schwartzentruber, D. J. and Rosenberg, S. A. (1992) Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes. J. Immunother. 12, 203-206.
16. van der Bruggen, P., Szikora, J.-P., Boel, P., Wildmann, C., Somville, M., Sensi, M. and Boon, T. (1994) Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol. 24, 2134-2140.
17. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T. and Rosenberg, S. A. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91, 3515-3519.
18. Chen, P., Murray, T. G., Toshihiko, U., Salgaller, M. L., Reddy, R. and Ksander, B. R. (1997) Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin. Exp. Metastasis 15, 509-518.
19. McGovern, V. J., Shaw, H. M., Milton, G. W. and Farago, G. A. (1981) Lymphocytic infiltration and survival in malignant melanoma. In Pathology of Malignant Melanoma (Ed. Ackerman, A. B.). Pp. 341-344. Masson Publishing, New York.
20. Blom, D. R., Luyten, G. P. M., Mooy, C., Kerkvliet, S., Zwinderman, A. H. and Jager, M. J. (1997) Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 38, 1865-1872.
21. Apte, R. S., Mayhew, E. and Niederkorn, J. Y. (1997) Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest. Ophthalmol. Vis. Sci. 38, 1277-1282.
22. Apte, R. S. and Niederkorn, J. Y. (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156, 2667-2673.
23. Muul, L. M., Spiess, P. J., Director, E. P. and Rosenberg, S. A. (1987) Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138, 989-995.
24. Verbik, D., Murray, T. G. and Ksander, B. R. (1997) Melanomas that develop within the eye inhibit stimulation of T cells. Int. J. of Cancer. In Press.